Event Type
Disclosure
Mandatory
Variant
8-K
. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, BioAtla, Inc. (the “Company”) receiv
Regulation FD. As previously disclosed, on November 20, 2025, the Company entered into Pre-Paid Advance Agreements (the “PPAs”) with each of YA II PN, Ltd., a C